Sales increased 1.6% year over year to 1,955.936 million yen, operating income declined 36.0% to 72.876 million yen, and net income attributable to owners of the parent was 58.686 million yen. For the 2027 fiscal year, consolidated results outlook: revenue of 1,962 million yen, operating income of 74 million yen, ordinary income of 106 million yen, net income attributable to owners of the parent of 60 million yen. By segment: Optical business sales 1,426 million yen, Life Science \/ Instrument Development business 284 million yen, others 244 million yen. As a full-year business strategy, continue to push Innovation2030. No major changes in share-related matters.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3446","jir_company_name":"J-TECH Corporation Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3446-20260810-01.pdf","jir_short_summary":"Sales increased 1.6% year over year to 1,955.936 million yen, operating income declined 36.0% to 72.876 million yen, and net income attributable to owners of the parent was 58.686 million yen. For the 2027 fiscal year, consolidated results outlook: revenue of 1,962 million yen, operating income of 74 million yen, ordinary income of 106 million yen, net income attributable to owners of the parent of 60 million yen. By segment: Optical business sales 1,426 million yen, Life Science \/ Instrument Development business 284 million yen, others 244 million yen. As a full-year business strategy, continue to push Innovation2030. No major changes in share-related matters.","jir_summary":"### Performance overview\nOur group is pursuing growth centered on three business lines, with consolidated revenue for the six months ending June 2026 of 1,955,936 thousand yen (up 1.6% YoY) and operating income of 72,876 thousand yen (down 36.0% YoY). By segment, Optical business revenue was 1,426,661 thousand yen (up 15.6% YoY), Life Science \/ Instrument Development business was 284,392 thousand yen (up 28.9%), and others were 244,882 thousand yen with no notable major changes. The company will continue to advance mid-to-long-term growth strategy centered on Innovation2030.\n\n### Outlook and challenges\nFor the fiscal year ending March 2027, consolidated forecasts are revenue of 1,962 million yen, operating income of 74 million yen, ordinary income of 106 million yen, and net income attributable to owners of the parent of 60 million yen. Due to the fiscal year-end change, the next consolidated fiscal year will be a nine-month period, so year-over-year comparisons are not immediately provided. In the Optical business, demand for high-precision mirrors is expected to rise, and in Life Science, continued expansion of automated culture devices and development of new markets will be pursued. The goal is to improve profitability through new product development and cost management.","jir_financial_highlights":"Revenue: 1,955,936\u5343\u5186 (YoY +1.6%)\nOperating income: 72,876\u5343\u5186 (YoY -36.0%)\nOrdinary income: 84,381\u5343\u5186 (YoY -17.3%)\nNet income attributable to owners of the parent: 58,686\u5343\u5186 (YoY -2.8%)\nTotal assets: 3,610,675\u5343\u5186 (YoY decrease 77,456\u5343\u5186)","jir_category":"","jir_hashtags":"#J-TECHCorporation, #FinancialResult, #MediumTermManagementPlan","jir_key_figures":"Revenue: 1,955,936\u5343\u5186\uff08YoY +1.6%\uff09\nOperating income: 72,876\u5343\u5186\uff08YoY -36.0%\uff09\nNet income attributable to owners of the parent: 58,686\u5343\u5186\uff08YoY -2.8%\uff09","jir_meta_title":"\u3010J-TECH Corporation\u3011Six Months Ended June 2026 Financial Summary | Revenue 1,955 million yen; Net income 5,868 thousand yen","jir_meta_description":"Summary of J-TECH Corporation's six months ended June 2026. Revenue 1,955,936 thousand yen, operating income 72,876 thousand yen, net income 58,686 thousand yen. By segment: Optical 1,426,661 thousand yen, Life Science 284,392 thousand yen. Going forward, growth pursued centered on Innovation2030.","jir_og_title":"J-TECH Corporation Earnings Announcement | Revenue 1,955 million yen; Net income etc.","jir_og_description":"J-TECH Corporation six-month 2026 results. Revenue is roughly flat YoY, operating income decreased. Commentary on outlook and segment status.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59399,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-100335","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n